Young NS. Aplastic anemia. N Engl J Med. 2018;379:1643–56.
Article CAS PubMed PubMed Central Google Scholar
Furlong E, Carter T. Aplastic anaemia: current concepts in diagnosis and management. J Paediatr Child Health. 2020;56:1023–8.
Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017;129:1428–36.
Article CAS PubMed Google Scholar
Yoshida N, Kobayashi R, Yabe H, Kosaka Y, Yagasaki H, Watanabe K, et al. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy. Haematologica. 2014;99:1784–91.
Article PubMed PubMed Central Google Scholar
Dufour C, Veys P, Carraro E, Bhatnagar N, Pillon M, Wynn R, et al. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK paediatric BMT working party, paediatric diseases working party and severe aplastic anaemia working party of EBMT. Br J Haematol. 2015;171:585–94.
Article CAS PubMed Google Scholar
Ohara A, Kojima S, Hamajima N, Tsuchida M, Imashuku S, Ohta S, et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 1997;90:1009–13.
Article CAS PubMed Google Scholar
Socie G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al. Malignant tumors occurring after treatment of aplastic anemia. European bone marrow transplantation-severe aplastic anaemia working party. N Engl J Med. 1993;329:1152–7.
Article CAS PubMed Google Scholar
Yoshida N, Yagasaki H, Hama A, Takahashi Y, Kosaka Y, Kobayashi R, et al. Predicting response to immunosuppressive therapy in childhood aplastic anemia. Haematologica. 2011;96:771–4.
Article PubMed PubMed Central Google Scholar
Narita A, Zhu X, Muramatsu H, Chen X, Guo Y, Yang W, et al. Prospective randomized trial comparing two doses of rabbit anti-thymocyte globulin in patients with severe aplastic anaemia. Br J Haematol. 2019;187:227–37.
Article CAS PubMed Google Scholar
Cui L, Moraga I, Lerbs T, Van Neste C, Wilmes S, Tsutsumi N, et al. Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors. Proc Natl Acad Sci U S A. 2021;118: e2017849118.
Article CAS PubMed Google Scholar
Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, et al. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood. 2014;123:1818–25.
Article CAS PubMed PubMed Central Google Scholar
Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, et al. Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med. 2022;386:11–23.
Article CAS PubMed Google Scholar
Yamazaki H, Ohta K, Iida H, Imada K, Obara N, Tokumine Y, et al. Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy. Int J Hematol. 2019;110:187–96.
Article CAS PubMed Google Scholar
Imada K, Obara N, Iida H, Imajo K, Maeda T, Usuki K, et al. Eltrombopag in combination with rabbit anti-thymocyte globulin/cyclosporine a in immunosuppressive therapy-naïve patients with aplastic anemia in Japan. Intern Med. 2021;60:1159–68.
Article CAS PubMed Google Scholar
Marrapodi MM, Mascolo A, Roberti D, Martino MD, Rafaniello C, Riccardi C, et al. The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic review. Front Pediatr. 2023;11:1149718.
Article PubMed PubMed Central Google Scholar
Groarke EM, Patel BA, Gutierrez-Rodrigues F, Rios O, Lotter J, Baldoni D, et al. Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia. Br J Haematol. 2021;192:605–14.
Article CAS PubMed PubMed Central Google Scholar
Fang M, Song H, Zhang J, Li S, Shen D, Tang Y. Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: a Chinese retrospective study. Pediatr Hematol Oncol. 2021;38:633–46.
Article CAS PubMed Google Scholar
Lesmana H, Jacobs T, Boals M, Gray N, Lewis S, Ding J, et al. Eltrombopag in children with severe aplastic anemia. Pediatr Blood Cancer. 2021;68: e29066.
Article CAS PubMed Google Scholar
Filippidou M, Avgerinou G, Tsipou H, Tourkantoni N, Katsibardi K, Vlachou A, et al. Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia. Br J Haematol. 2020;190:e157–9.
Goronkova O, Novichkova G, Salimova T, Kalinina I, Baidildina D, Petrova U, et al. Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia. Blood Adv. 2023;7:953–62.
Article CAS PubMed Google Scholar
Fan X, Desmond R, Winkler T, Young DJ, Dumitriu B, Townsley DM, et al. Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias. Blood Adv. 2020;4:1700–10.
Article CAS PubMed PubMed Central Google Scholar
Giudice V, Selleri C. Aplastic anemia: pathophysiology. Semin Hematol. 2022;59:13–20.
Patel BA, Groarke EM, Lotter J, Shalhoub R, Gutierrez-Rodrigues F, Rios O, et al. Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study. Blood. 2022;139:34–43.
Article CAS PubMed PubMed Central Google Scholar
Değirmenci BB, Yegin ZA, Dikyar A, Kaynar LA, Nur Özkurt Z, Göçün PU, et al. Eltrombopag may induce bone marrow fibrosis in allogeneic hematopoietic stem cell transplant recipients with prolonged thrombocytopenia. Leuk Res. 2022;118: 106870.
Kubota I, Nagasawa S, Nakagawa M, Yamada A, Kinoshita M, Kamimura S, et al. Successful treatment of eltrombopag following immunosuppressive therapy in pediatric aplastic anemia. Rinsho Ketsueki. 2023;64:741–5.
留言 (0)